Analyzers and Readers

Analyzers and Readers

Find the high-performance equipment you need to detect a variety of infections rapidly and accurately. A range of molecular analyzers and platforms can help you diagnose influenza A and B, RSV, strep A, and COVID-19. Our selection of clinical analyzers includes camera-based benchtop instruments, rapid chromatography immunoassay analyzers, and instruments offering microfluidic technology that deliver results in minutes.

Information About Molecular Analyzers

Molecular analyzers, also known as molecular diagnostic devices or molecular testing platforms, are advanced tools used to detect and identify specific genetic materials (such as DNA or RNA) of pathogens like viruses or bacteria. They play a crucial role in diagnosing respiratory illnesses, especially during outbreaks or pandemics, where rapid and accurate identification of pathogens is essential for timely patient management and public health interventions. Following is more information about molecular analyzers offered by the Fisher Healthcare brand.

Abbott ID NOW System (formerly Alere i)

The Abbott™ ID NOW™ System uses isothermal nucleic acid amplification technology to detect influenza A and B viral nucleic acids. The CLIA-waived methods include all the necessary testing components, and the analyzer offers barcode technology and LIS connectivity. Assays available for this platform include influenza A and B, RSV, strep A, and COVID-19.

Meridian Bioscience Revogene Instrument

Capable of single analyte or multiplex testing, the Meridian Bioscience™ Revogene™ molecular platform can help you standardize testing. Its fully automated molecular platform offers minimal hands-on time in a flexible, scalable platform that can be expanded to meet your changing needs. Performs homogenization, microorganism lysis, dilution, amplification, and detection of target nucleic acid sequences from multiple specimens using fluorescence-based real-time PCR. Assays are available for SARS-CoV-2, strep A, and several other non-respiratory infections.

QuidelOrtho Solana Molecular Platform

The QuidelOrtho™ Solana™ Molecular Platform provides influenza A and B results in 45 minutes and performs up to 12 tests per run. The analyzer includes access to the QuidelOrtho proprietary wireless data management and surveillance system. Other CLIA-moderate assays for bacterial infections and infectious diseases are available for the Solana platform.

Information About Clinical Analyzers and Readers

Clinical analyzers help detect and measure various parameters, biomarkers, and analytes in patient samples. They are essential in diagnosing respiratory illnesses because they provide valuable information about the patient's health status and aid healthcare professionals in making accurate and timely treatment decisions. Following is more information about clinical analyzers and readers offered by the Fisher Healthcare brand.

Abbott DIGIVAL Reader

The Abbott™ DIGIVAL™ Reader is a camera-based benchtop instrument that can objectively interpret results by using a camera to detect the presence of influenza types A and B and identify a completed lateral flow assay, analyze the intensity of the test and control line, and display the results (positive, negative, or invalid) on the color touchscreen.

BD Veritor Plus System

The BD Veritor™ Plus System is a rapid chromatography immunoassay analyzer for the qualitative detection of influenza A and B viral nucleoprotein antigens. The system is CLIA-waived for nasal and nasopharyngeal swabs and offers two modes: Analyze Now and Walk Away. This multi-assay platform includes tests for influenza A and B, RSV, and strep A.

LumiraDx Instrument

Innovative microfluidic technology delivers results in minutes when used with LumiraDx SARS-CoV-2 Ag Test strips. Authorized by FDA under EUA for use by laboratories certified under the CLIA, 42 U.S.C. §263a.

QuidelOrtho Sofia 2 Analyzer

The QuidelOrtho™ Sofia™ 2 Analyzer accurately detects influenza A and B from nasal swabs, nasopharyngeal swabs, and nasal aspirate/wash samples. Its CLIA-waived procedure can produce dual test results from a single sample. The instrument features an easy-to-use interface with customizable settings.

Sekisui Diagnostics Acucy Reader

The Sekisui Diagnostics Acucy™ Reader System provides standardized test results in 15 minutes for CLIA-waived procedures. Use with the Sekisui Influenza A&B Test Kit.


Featured Products

Molecular Analyzers

Clinical Analyzers and Readers

Shop by Brand